Feature | Nick Obradovich
The only safe assumption to make about today’s current gold standard imaging modality used to identify and evaluate atheromatous plaque in the peripheral arteries is that there is not one gold standard. To locate and evaluate these plaques that cause peripheral vascular disease (PVD), physicians have multiple tried-and-true imaging tests at their disposal.
July 09, 2008
News
July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has ...
July 09, 2008
Feature | Maureen Leahy-Patano
Safe delivery of the balloon or stent through fragile vasculature during percutaneous transluminal coronary angioplasty (PTCA) procedures is an important criterion for successful patient outcomes.
July 09, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025
Feature | Cristen Bolan
Cardiology fellows are expanding their knowledge in cardiovascular imaging. Not only do virtually all cardiology fellows get Level 2 training in echocardiography and many in nuclear cardiology but now, an increasing number of fellows are training in cardiac MR and cardiac CT.
July 09, 2008News
July 10, 2008 - The Senate overcame partisan gridlock on July 9, 2008, and passed the Medicare Improvements for Patients ...
July 09, 2008Feature | Cristen Bolan
What makes cardiologists more capable of reading cardiac imaging exams than other physicians such as radiologists, who ...
July 09, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Feature | Stents | Ellen W. Rothschild, RN, MS
(Editor's note: this article was updated in March 2017 with links at the bottom to more current stent technology ...
July 09, 2008
Feature | Archana Swathy, Research Analyst, Frost & Sullivan
Physicians recognize the importance of ventricular assist devices (VADs) every time a congestive heart failure (CHF) ...
July 09, 2008News
July 10, 2008 - Boston Scientific Corp. this week launched its Atlantis .018 Peripheral Imaging Catheter, which reportedly brings existing 40 MHz coronary standard ultrasound imaging resolution to peripheral interventions. The company said the product is available for immediately release in the U.S.
July 09, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology
The ACUSON SC2000 volume imaging ultrasound system acquires nonstitched, real-time full-volume 3D images of the heart in ...
July 08, 2008Technology
The Sorin Group said the FDA approved to market the CRT model of its OVATIO family, reportedly the smallest CRT defibrillator (CRT-D) available. The OVATIO CRT 6750 is shaped to offer ease of implantation and long-term patient comfort, and is designed to allow more flexibility in the management of cardiac resynchronization and antitachyarrhythmia therapy due to its Brady-Tachy Overlap (BTO).
July 08, 2008
Technology
Recently introduced at the Heart Rhythm Society (HRS 2008) meeting, the new DigiTrak XT Holter recorder is reportedly equipped with powerful and innovative technology aimed at simplifying the patient and clinical user experience.
July 08, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
July 9, 2008 - Summit Doppler Systems this week introduced a significant upgrade to the Vista AVS, a full-featured ...
July 08, 2008
Technology
Siemens' ACUSON SC2000 volume imaging ultrasound system acquires nonstitched, real-time full-volume 3D images of the heart in one single heart cycle. Called “Echo in a Heartbeat,” this new technology generates nonstitched full-volume imaging reportedly of the entire heart with 90 degree pyramids and in just one second.
July 08, 2008Technology
Angiotech Pharmaceuticals Inc. received 510(k) clearance from the FDA to market its 5-Fluorouracil (5-FU) coated central venous catheter (CVC).
July 08, 2008